Scientists uncover 'striking' immune cell populations poised to fight SARS-CoV-2 in upper airway. Scientists at La Jolla Institute for Immunology (LJI) have published the first-ever, in-depth analysis of immune cell memory in the upper airways of adult volunteers. Among these immune cells, the researcher spotted "tissue resident" memory cells, which stand ready to defend the
Scientists have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so, they have pinpointed an exciting new target for drug developers. Irish scientists led by a group from Trinity College Dublin have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so
Scientists uncover 'striking' immune cell populations poised to fight SARS-CoV-2 in upper airway. Scientists at La Jolla Institute for Immunology (LJI) have published the first-ever, in-depth analysis of immune cell memory in the upper airways of adult volunteers. Among these immune cells, the researcher spotted "tissue resident" memory cells, which stand ready to defend the
Scientists uncover 'striking' immune cell populations poised to fight SARS-CoV-2 in upper airway. Scientists at La Jolla Institute for Immunology (LJI) have published the first-ever, in-depth analysis of immune cell memory in the upper airways of adult volunteers. Among these immune cells, the researcher spotted "tissue resident" memory cells, which stand ready to defend the
A new study provides evidence that a spillover of avian influenza from birds to dairy cattle across several U.S. states has now led to mammal-to-mammal transmission -- between cows and from cows to cats and a raccoon. A new Cornell University study provides evidence that a spillover of avian influenza from birds to dairy cattle
Scientists have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so, they have pinpointed an exciting new target for drug developers. Irish scientists led by a group from Trinity College Dublin have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so
Has already established an infection, but what if a drug could prevent infection in the first place? Now, scientists have designed drug-like molecules to do just that, by thwarting the first stage of influenza infection. This groundbreaking approach could revolutionize the way we treat and prevent the flu, offering a new level of protection against this commonly contracted virus. With the potential to significantly reduce the spread and impact of influenza, this innovative development could change the landscape of flu prevention and treatment
Ducks in the Midwest, is capable of infecting and spreading among cattle. This discovery raises concerns about potential cross-species transmission and highlights the need for continued surveillance and biosecurity measures to prevent further spread of the virus. The ability of H5N1 to infect multiple species underscores the importance of vigilant monitoring and rapid response to protect both animal and human health
Highlights the potential risk of avian flu transmission from wild birds to humans and domestic poultry. The study's findings underscore the importance of ongoing surveillance and monitoring efforts to prevent the spread of avian influenza in urban environments. This research provides valuable insight for public health officials and policymakers in developing strategies to mitigate the threat of avian flu outbreaks in densely populated areas
Of effective treatments for IAE, this discovery offers hope for new therapeutic strategies to combat this dangerous condition. The identification of endothelial cells as a key site for viral entry provides valuable insight into the pathogenesis of IAE and opens up new possibilities for targeted interventions. This groundbreaking research has the potential to revolutionize the way we approach and treat influenza-associated encephalopathy, bringing us closer to effective management and improved outcomes for patients
Made a breakthrough in flu vaccine development with the creation of an experimental vaccine containing over 80,000 variations of hemagglutinin antigens. This innovative approach has shown to elicit a stronger immune response in mice and ferrets, targeting less variable portions of the virus. This promising development brings us closer to the goal of a universal, long-lasting flu shot. The work of the Duke Human Vaccine Institute marks a significant advancement in the fight against influenza
Against the flu more effectively compared to mice on a high-fat diet. This suggests that improving metabolic health before vaccination may enhance vaccine effectiveness. This has important implications for public health, as it highlights the need to address obesity and metabolic health in order to improve the efficacy of the annual flu vaccine
Discovered that this new drug can effectively target and reduce inflammation without compromising the body's ability to fight off the virus. This breakthrough offers hope for treating severe cases of the flu and potentially other respiratory infections. With its ability to strike a balance between curbing inflammation and supporting the immune response, this drug could revolutionize the way we approach and treat viral infections. Its potential to save lives and improve patient outcomes makes it a game-changer in the field of infectious disease management
